companydata.dkcompanydata.dk

ABBVIE A/S: Financial statements 2024

CVR: 34462828

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

ABBVIE A/S (CVR 34462828) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 336,906,684 and a net result of DKK 11,055,919 compared with DKK 13,734,586 the year before. That is an increase of 16.9% compared with the year before. The profit margin was 3.3%. Equity in the 2024 report amounted to DKK 72,988,395. The solvency ratio was 35.4%. The company had 48 employees in the financial year.

Revenue
DKK 336,906,684
Gross Profit
DKK 75,123,911
Profit/Loss
DKK 11,055,919
Equity
DKK 72,988,395
Total Assets
DKK 206,042,940
Employees
48

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024336.9 mio.75.1 mio.11.1 mio.73 mio.48
2023288.1 mio.77.2 mio.13.7 mio.61.9 mio.52
2022285 mio.81.7 mio.12.2 mio.196.2 mio.52
2021292.4 mio.75 mio.11.2 mio.184 mio.48
2020183.9 mio.60.1 mio.7 mio.156.6 mio.42

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

ABBVIE A/S wins public contractDec 10, 2024

ABBVIE A/S has won the tender "Amgros 2025 1.351.b" issued by Amgros I/S worth 22,702,680,000 DKK.

ABBVIE A/S: The 2023 annual report is outJun 21, 2024

ABBVIE A/S has published its annual report for 2023. Revenue came to DKK 288,128,360, and the net result was DKK 13,734,586.

ABBVIE A/S wins public contractMay 7, 2024

ABBVIE A/S has won the tender "Amgros 2024 1.352.a" issued by Amgros I/S worth 78,400,000 DKK.

ABBVIE A/S wins public contractMay 6, 2024

ABBVIE A/S has won the tender "Amgros 2024 1.168.a" issued by Amgros I/S worth 1,673,000,000 DKK.

ABBVIE A/S wins public contractApr 25, 2024

ABBVIE A/S has won the tender "Amgros 2024 1.351.b" issued by Amgros I/S worth 19,644,800,000 DKK.

Shitra Irari Amozurrutia Blancas joins the board of ABBVIE A/SFeb 1, 2024

As of February 1, 2024, Shitra Irari Amozurrutia Blancas has joined the board of directors of ABBVIE A/S.

Emilie Claudine Demare leaves the board of ABBVIE A/SFeb 1, 2024

As of February 1, 2024, Emilie Claudine Demare has left the board of directors of ABBVIE A/S.

About ABBVIE A/S

ABBVIE A/S is a Danish company of the type Aktieselskab based in København N, founded in 2012. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named WCA PHARMACEUTICALS A/S. The management consists of Thea Larsen. The board consists of Matthew Robert Iles (chair), Arnaud Jean Jacques Coint-Bavarot, Jens Lange and Shitra Irari Amozurrutia Blancas. The company is owned by AbbVie Central Finance B.V.. The company has 59 employees (2026). In 2025, the company reported revenue of DKK 472,957,984 and a net result of DKK 25,023,523 compared with DKK 11,055,919 the year before. Equity in the 2025 report amounted to DKK 98,011,918.

Source: annual report 2025, Danish Business Authority